Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis

NCT05961956 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Degenerative Lumbar Spondylolisthesis

Interventions

DRUG: NVDX3

Sponsor

Novadip Biosciences